Thu, Aug 21, 2014, 6:46 AM EDT - U.S. Markets open in 2 hrs 44 mins


% | $
Quotes you view appear here for quick access.

China Nepstar Chain Drugstore Ltd. Message Board

ajetjock 53 posts  |  Last Activity: Aug 11, 2014 12:35 AM Member since: Mar 11, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    A Challange for the Shorts on here........

    by samsa1 Aug 8, 2014 8:43 AM
    ajetjock ajetjock Aug 11, 2014 12:35 AM Flag

    EXACTLY WIMusky !

    Well said.

    Sentiment: Strong Buy

  • ajetjock by ajetjock Aug 7, 2014 10:09 AM Flag

    Looking at the BIG pic in ref to recent events and the age of the VERY talented SNTA BOD...

    The HUGE number of shares they own and NEVER sold.

    And it becomes apparent that they are ready to get a RETURN on their investment.

    And sooner, rather than later.

    The new CEO is just one more step in that (right) direction.

    Sentiment: Strong Buy

  • ajetjock ajetjock Aug 6, 2014 10:16 AM Flag

    BINGO ! They just CONFIRMED this in the Conf call: They ARE looking past approval and the COMMERCIALIZATION of the products.

    Sentiment: Strong Buy

  • Reply to

    Over sold......

    by samsa1 Aug 5, 2014 10:16 AM
    ajetjock ajetjock Aug 5, 2014 1:22 PM Flag

    I sure appears as if the risk / reward is now favoring the reward of BUYING IPCI at this level.

    I will not be surprised if we end up green today as we start the reversal, which should accelerate tremendously should we also get new approval/s.

    Sentiment: Strong Buy

  • ajetjock ajetjock Aug 5, 2014 12:28 PM Flag

    Even if there is nothing good...we MUST have reached the point of Max negativity and the risk /reward level are now favoring BUYING SNTA.

    Now IF there are positive news..

    And IF you look at the chart; We have been EXACTLY at this very same level in Nov last year. After which SNTA shot up to 5 in a week and a couple of months later to 7.


    Sentiment: Strong Buy

  • ajetjock by ajetjock Aug 5, 2014 12:43 AM Flag

    In spite of your constant drivel, IPCI HAS proved the CONCEPT with first approval and IMMEDIATE distribution via PAR.

    The rest of the ANDAs WILL follow... Just as your drivel shows here DAILY when IPCI goes down and just as you disappear when the stock moves up.

    It never fails.

    Sentiment: Strong Buy

  • Reply to

    Shorty: IPCI is moving HIGHER.

    by ajetjock Jul 30, 2014 2:46 PM
    ajetjock ajetjock Jul 30, 2014 4:09 PM Flag

    And it DID...

    Now corrected and heading HIGHER again.

    Your problem is that you are EMOTIONAL and always on the wrong side of the trade.

    One of these days...You too will learn to buy LOW and sell HIGH.

    Not the other way around.

    Until then: Good luck !

    Sentiment: Strong Buy

  • It does not matter how much B$ you post.

    Get used to it.

    Sentiment: Strong Buy

  • Reply to

    Purdue Targiniq ER

    by wimuskyfisherman Jul 24, 2014 10:04 AM
    ajetjock ajetjock Jul 25, 2014 12:20 AM Flag

    Not sure where you got your 18 M as the norm. Teva had 3 years PLUS ANDAs.

    Sentiment: Strong Buy

  • ajetjock ajetjock Jul 20, 2014 11:24 PM Flag

    YES !

    I like the CEO comment !

    If Gollust is the default CEO, we are doing VERY well !

    Mind you that SNTA has EXTREMELY talented Board. Both in the pharma field as well as financial.

    I will post info on all members below and aside from Gollust , pay attention to Friedman. For those who remember Friedman was the INCY (Incyte Corp) CEO. The Co was sold and the stock consequently did VERY well (20 to a high of 70 if I recall.)

    We also know that ALL SNTA insiders OWN a LOT of SNTA stock and NOT ONE has sold ! Not even the former CEO.


    Keith R. Gollust Director and Chairman

    Keith R. Gollust has been a member of our Board of Directors since July 2002 and has been our Chairman since September 2002. Mr. Gollust is a private investor and President of Gollust Management, Inc., the general partner of Wyandanch Partners, an investment partnership. In the past, Mr. Gollust has served as a director of numerous public and private companies. Mr. Gollust currently serves as a director of CastleLine Holdings, LLC, an insurance holding company and Script Relief, LLC, a discount prescription drug company. He also is a member of the Board of Trustees of The Julliard School. Mr. Gollust received a B.A. from Princeton University and an MSIA from Carnegie Mellon University. Our Board of Directors has concluded that Mr. Gollust should serve as a director as of the date of this proxy statement based on his past service on the Board of Directors of four other publicly traded companies and his experience as managing general partner of various investment partnerships which gave him responsibility for investing over $1 billion as a fiduciary. [Back to Top]

    Paul A. Friedman, M.D. Director

    Paul A. Friedman, M.D. was the Chief Executive Officer and a Director of Incyte Corporation from November 2001 and and also its President from May 2004 until his retirement in January 2014. Dr. Friedman has been a Director of Durata Therapeutics, Inc. since May 16, 2013. He has been a Non E

    Sentiment: Strong Buy

  • ajetjock ajetjock Jul 16, 2014 11:12 AM Flag

    And every single share I hold is also "still intact".

    Waiting for a much higher price. Like Jennings.

    Sentiment: Strong Buy

  • IPCI DID prove their concept. Once their first drug was approved, it was IMMEDIATELY ready for marketing by PAR Pharma.

    IPCI FLOAT is still MINIMAL !

    Patience and confidence are the KEY to investing. Don't let smoke, mirrors, fear and attempted manipulation by the likes of Maxim to distract you.

    It is only a matter of time before the next drug/s will get FDA approval.

    We are VERY close on at least 3 drugs.

    Again: The float is ONLY: 17 M.

    40% of shares is help by INSIDERS . They want to see it appreciating. Just like the rest of us, LONG investors.

    Focus !

    Sentiment: Strong Buy

  • Reply to

    Technicial BS

    by syenfrout Jul 10, 2014 11:24 AM
    ajetjock ajetjock Jul 11, 2014 12:35 AM Flag

    Well said !

    Especially : "Patience and confidence in the product that you invest in makes the difference. "

    Sentiment: Strong Buy

  • Reply to

    IPCI Fear

    by dr_c6 Jul 9, 2014 11:48 PM
    ajetjock ajetjock Jul 11, 2014 12:30 AM Flag

    Bingo !

    It is funny how every time SHORTS smell blood, even if FOR NO GOOD REASON, as is the case with IPCI, you see NEW IDs around stock boards, ready to enlighten us and tell us how bad IPCI or XXXX is...

    Folks should know that when is FEAR, it is time to BUY. *NEVER* sell in fear or panic .

    FACT is : NOT a thing has changed ! BUT IPCI has FAR MORE CASH on hand than they had before.

    This JOKE for a "downgrade" clearly meant to MANIPULATE the stock price either for shorts or to buy at lower price for longs.

    I am NOT selling as I KNOW that this stock WILL move up fast once the new approvals are announced.

    Just as it did before when the first drug was approved and IMMEDIATELY was ready to be marketed by PAR .

    Sentiment: Strong Buy

  • ajetjock ajetjock Jul 9, 2014 1:12 PM Flag

    And they have said NOTHING meaningful with their report. TOTAL BS !

    Besides how many other more valid firms have we seen coming up with sell/ but AFTER the facts ?

    One thing they did, is create a BUYING opportunity today.

    Sentiment: Strong Buy

  • In fact the company now has FAR MORE cash, the SAME pipleine , same drugs waiting FDA approvals and SAME potential they had few weeks ago.

    The only change is that the report provided shorts an opportunity to sling BS and obviously some of it sticks to the walls.

    Remember: You BUY low (today) you don't sell low. For SURE not in panic and for NO GOOD REASON !

    Sentiment: Strong Buy

  • ajetjock ajetjock Jul 9, 2014 12:48 PM Flag

    NOTHING has changed in regards to future catalysts with the pipeline waiting approval.

    They (IPCI)HAVE proven the concept.

    The only difference is that today, the shorts can sling all kind of MADE UP BS.

    Sentiment: Strong Buy

  • IPCI float is a MINIMAL 17M !

    TOTAL number of shares is also minimal at 23M.

    Go and check these numbers on ANY other pharma...

    Now, ALL pharma survive on issuing stock UNTIL they have enough revenue as a result of FDA approved products.

    This IS simply how the business operates, and it seems that SHORTS trying to pray on naive longs, use this fact against the longs in a campaign of FEAR. Same happens with almost ALL pharma.

    REALITY: As we see from the MINIMAL number of shares, IPCI has been VERY responsible and is NOT issuing too many shares.

    Another reality: INSIDERS own 40% of the shares ! Hence they too have the same interests as long investors : enhance shareholders value.

    I do not know of any other pharma but SNTA, where insiders are so heavily invested in the Co.


    With multiple drugs in the pipline, and several pending practically ANY DAY, revenue WILL increase very likely this year.

    Smart investors buy EARLY.

    With the LOW FLOAT we have at IPCI, buying after the news, will cost you. As we have seen with previous approval the stock moved from less than 2 to 6.5 ...FAST.

    IGNORE the SHORTS ! Why would anyone hang around a stock they don't like ??? Unless they want YOU to fear and sell.


    Sentiment: Strong Buy

  • At May 31, 2014, Intellipharmaceutics' cash totaled $7.3 million, compared with $0.8 million at November 30, 2013.

    Sentiment: Strong Buy

  • Reply to

    What is the next catalyst?

    by hsangha56 Jul 7, 2014 2:36 PM
    ajetjock ajetjock Jul 7, 2014 10:52 PM Flag

    So aside from multiple patents and potential FDA approval, we also have the CEO search ongoing with potential announcement any time. I suspect that announcement to be another significant catalyst.
    Even thought the SNTA board is VERY talented and handles the company just fine.

    Sentiment: Strong Buy

2.25-0.02(-0.88%)Aug 20 4:02 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.